GGrantIndex
Sort

53,477 grants matching addiction

CAREER: Using Information and Incentives to Promote Human Capital

$475,129
Rebecca Dizon-Ross · National Bureau Of Economic Research Inc · · FY2019 · SBE

Linking Opioid Dependent Patients from Inpatient Detoxification to Primary Care

$475,128
Michael D Stein · Butler Hospital (Providence, Ri) · R01 · FY2016 · DA

Dental and medical office iMET to reduce teen tobacco, alcohol, and drug use

$475,105
John R Knight · Boston Children'S Hospital · RC1 · FY2009 · DE

CDP-choline treatment in amphetamine type stimulant-using adolescents

$475,077
Perry Franklin Renshaw · University Of Utah · R01 · FY2015 · DA

Applying Big Data Analytics to Study the Impact of Opioid Prescribing Policy Changes on Prescribing Behavior and Overdose Outcomes

$475,024
Jason M Glanz · Kaiser Foundation Research Institute · R56 · FY2017 · DA

Function and Regulation of Postsynaptic Serine Racemase

$474,976
John Alan Gray · University Of California At Davis · R01 · FY2022 · MH

Function and Regulation of Postsynaptic Serine Racemase

$474,976
John Alan Gray · University Of California At Davis · R01 · FY2021 · MH

Function and Regulation of Postsynaptic Serine Racemase

$474,976
John Alan Gray · University Of California At Davis · R01 · FY2023 · MH

Targeting the heat shock response for the therapy of DLBCL

$474,862
Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · CA

Screen, Treat and Retain Meth-Using People with Opioid Use Disorders at MMT Clinics (STAR-OM)

$474,840
Giang M Le · Hanoi Medical University · R01 · FY2022 · DA

Development of Nav1.7 Monoclonal Antibodies for Treating Pain

$474,833
Joseph Benjamin Rucker · Integral Molecular · R43 · FY2021 · NS

Pretreatment Change in Drinking: Relationship to Treatment Outcome

$474,785
Paul R Stasiewicz · State University Of New York At Buffalo · R01 · FY2018 · AA

Improving Access to Cigarette Cessation Treatment Among African American Smokers: Development and Evaluation of an Integrated mHealth Application

$474,784
Michael J Zvolensky · University Of Houston · U54 · FY2024 · MD

Pre-clinical testing of a novel immunotherapy [recombinant T cell receptor ligand

$474,779
Jennifer M Loftis · Oregon Health & Science University · RC1 · FY2009 · DA

Interaction of Smoking and Chronic Pain at Neurochemical and Phenotypic Levels

$474,766
Jon-Kar Zubieta · University Of Michigan At Ann Arbor · R01 · FY2013 · DA

Immunopharmacotherapy for the Treatment of Cocaine Abuse

$474,750
Kim D Janda · Scripps Research Institute, The · R01 · FY2010 · DA

Vaccines for the Treatment of Opiate Addiction

$474,750
Kim D Janda · Scripps Research Institute, The · R01 · FY2010 · DA

Opioid Patients: Behavioral Family Counseling and Naltrexone

$474,736
Timothy James O'Farrell · Harvard Medical School · R01 · FY2007 · DA

Adoption Fidelity and Effectiveness of Alcohol SBIRT in Dental Practice

$474,730
James Alan Neff · Old Dominion University · RC1 · FY2009 · DE

PACAP-Dependent Coordination of Glutamate Signaling between Neurons and Astrocytes

$474,712
David A Baker · Marquette University · R01 · FY2021 · DA

Emotions and Choice: Mechanisms of Behavior Change

$474,705
Elizabeth A. Phelps · New York University · R01 · FY2014 · AG

Dissemination and Stakeholder Engagement Core

$474,608
Pamela F. Rodriguez · George Mason University · U2C · FY2020 · DA

Improving Access to Treatment for Women with Opioid Use Disorder

$474,596
Stephen W Patrick · Vanderbilt University Medical Center · R01 · FY2018 · DA

ALTERATIONS OF NEUROENDOCRINE STRESS RESPONSIVITY IN SPECIFIC ADDICTIVE DISEAS...

$474,572
Mary J Kreek · Rockefeller University · P60 · FY2007 · DA

Is mental disorder a preventable cause of age-related disease? The Dunedin Study.

$474,521
Terrie Edith Moffitt · Duke University · R01 · FY2012 · AG